Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Yorkshire company develops early diagnostic test for lung cancer

03.11.2004


A non-invasive diagnostic test for early-stage bronchial carcinoma (lung cancer) is one of the innovative technologies being presented at White Rose Bioscience Forum in York today (03 November).



Developed by Sheffield-based company Medis Diagnostics Ltd, the test - Fortel Bca - provides a reliable and accurate method of diagnosing early stage lung cancer through the analysis of a small blood sample which looks for cellular changes. The test uses data from a specially chosen panel of seven biomarkers, which, together with a patented ‘fuzzy logic’ mathematical process, provides the clinician with not only a benign/malignant diagnosis, but also a specific histology of any malignancy found. The test is cost-effective and offers high specificity and sensitivity and may bring diagnosis of lung cancer forward by up to 18 months.

Lung cancer is a difficult cancer to treat successfully as it frequently remains undiagnosed until it has reached the stage where a patient’s survival chances are low. Accurate earlier diagnosis through Fortel Bca could offer an immediate and significant improvement in the prognosis of those suffering from the disease. The test can also be used by clinicians at regular intervals to monitor the effectiveness of the treatment being given to lung cancer patients.


Medis Diagnostics is looking to raise additional funds of at least £300K to bring Fortel Bca to market. Presenting to an audience of venture capitalists at the BioForum’s investment track, Research and Development Director David Reed said:
“The diagnostic, predictive and classification information provided by Fortel Bca is more powerful than ever seen before. The number of new cases of lung cancer per year almost mirrors the number of deaths and there is a definite and proven need for our technology.”

This is the first time the annual White Rose University Consortium Bioscience Forum has held an investment track. The track is being run by Connect Yorkshire, an organisation that specialises in training and mentoring for high- tech companies seeking finance. Connect Yorkshire also organises twice-yearly investment conferences to bring technology companies together with potential investors.

Simon Browning, managing director of Connect Yorkshire says: “Clearly Medis Diagnostics has technology that will significantly change the outlook for those suffering from, or potentially suffering from lung cancer. Early diagnosis and novel monitoring methods will make an enormous difference to thousands of individuals in the future, demonstrating the importance of new technology in improving quality of life for all of us.”

Simon Donoghue, acting chief executive of the White Rose University Consortium says: “The investment track has demonstrated to delegates the wealth of novel bioscience research being undertaken in the region. We hope that this opportunity will result in further funding for the companies allowing their technologies to be developed further.”

Clare Elsley | alfa
Further information:
http://www.whiterose.ac.uk

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>